Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Study of Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Hormone Receptor-positive Breast Cancer.

NCT03906669 is registered in ClinicalTrials.gov with St Vincent's Hospital as lead sponsor.

NCT NCT03906669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03906669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Study of Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Hormone Receptor-positive Breast Cancer.
Lead sponsor
St Vincent's Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 20, 2018
Completion date
April 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer, hormone receptor positive tumor